| 2025 | Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitors | NATURE REVIEWS ENDOCRINOLOGY |
| 2025 | The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2025 | Meeting Physical Activity Guidelines: Impact on Chronic Kidney Disease Prevalence in Diabetic Individuals
| YONSEI MEDICAL JOURNAL |
| 2025 | Neuroprotective roles of SGLT2 and DPP4 inhibitors: Modulating ketone metabolism and suppressing NLRP3 inflammasome in T2D induced Alzheimer's disease | EXPERIMENTAL NEUROLOGY |
| 2025 | Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality
| CARDIOVASCULAR DIABETOLOGY |
| 2025 | Association of lean metabolic dysfunction-associated steatotic liver disease with carotid plaque progression in patients with type 2 diabetes mellitus | JOURNAL OF DIABETES INVESTIGATION |
| 2025 | Prevalence of mortality and vascular complication in older patients with diabetes in Korea
| Endocrinology and Metabolism(대한내분비학회지) |
| 2025 | Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular disease | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2025 | Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial
| BMC MEDICINE |
| 2025 | Potential Impact of Choline Alphoscerate on Depressive Symptoms in Association with Insulin Resistance in Elderly Patients with Type 2 Diabetes
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Regulation of senescence-associated secretory phenotypes in osteoarthritis by cytosolic UDP-GlcNAc retention and O-GlcNAcylation
| NATURE COMMUNICATIONS |
| 2024 | Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
| DIABETES & METABOLISM JOURNAL |
| 2024 | Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
| Endocrinology and Metabolism(대한내분비학회지) |
| 2024 | Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease
| CLINICAL AND TRANSLATIONAL MEDICINE |
| 2024 | SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes | NEUROLOGY |
| 2024 | Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naive patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial | DIABETES OBESITY & METABOLISM |
| 2024 | A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease | HEPATOLOGY INTERNATIONAL |
| 2024 | Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational Study
| ADVANCES IN THERAPY |
| 2024 | Modulating monocyte-derived macrophage polarization in cerebral ischemic injury with hyperglycemia | EXPERIMENTAL NEUROLOGY |
| 2024 | A self-powered and supercapacitive microneedle continuous glucose monitoring system with a wide range of glucose detection capabilities | BIOSENSORS & BIOELECTRONICS |
| 2024 | Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
| GUT AND LIVER |
| 2024 | In-depth correlation analysis between tear glucose and blood glucose using a wireless smart contact lens
| NATURE COMMUNICATIONS |
| 2024 | Alanine to glycine ratio is a novel predictive biomarker for type 2 diabetes mellitus | DIABETES OBESITY & METABOLISM |
| 2024 | Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2024 | Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial | DIABETES OBESITY & METABOLISM |
| 2024 | Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg?
| HEPATOBILIARY SURGERY AND NUTRITION |
| 2024 | Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2023 | SGLT2 and DPP4 inhibitors improve Alzheimer's disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse model
| BIOMEDICINE & PHARMACOTHERAPY |
| 2023 | Lean or non-obese nonalcoholic fatty liver disease patients: Are they really lean?
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells
| JOURNAL OF BIOLOGICAL CHEMISTRY |
| 2023 | Comparisons of the prediction models for undiagnosed diabetes between machine learning versus traditional statistical methods
| SCIENTIFIC REPORTS |
| 2023 | Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2023 | Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2023 | Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons
| NATURE COMMUNICATIONS |
| 2023 | β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 8 months | DIABETES & METABOLISM |
| 2023 | O-GlcNAcylation of RIPK1 rescues red blood cells from necroptosis
| FRONTIERS IN IMMUNOLOGY |
| 2023 | Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice
| DIABETOLOGIA |
| 2023 | Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial | DIABETES OBESITY & METABOLISM |
| 2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
| 2023 | Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2023 | Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial | EUROPEAN HEART JOURNAL |
| 2023 | Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2023 | Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
| DIABETES & METABOLISM JOURNAL |
| 2023 | Prognostic value of resting heart rate in predicting undiagnosed diabetes in adults: Korean National Health and Nutrition Examination Survey 2008–2018
| NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES |
| 2022 | Effect of low skeletal muscle mass and sarcopenic obesity on chronic kidney disease in patients with type 2 diabetes | OBESITY |
| 2022 | Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study
| JOURNAL OF DIABETES INVESTIGATION |
| 2022 | Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
| YONSEI MEDICAL JOURNAL |
| 2022 | Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
http://orcid.org/0000-0002-6219-4942
(56424219700)
